Investment/deal trends for emerging therapeutic companies 2009-2018

Global venture capital and public offerings 2009-2018, global licensing and acquisitions 2009-2018, 2019 global clinical pipeline

This report from mid-2019 identifies trends affecting emerging therapeutic companies across five core areas of investment and deal-making: venture capital, initial public offerings (IPOs), follow-on public offerings (FOPOs), licensing, and acquisitions. The report uses data from the most recent 10 years and categories are broken down by phase of development and disease area.

Please sign up for free to download this report.
More than 7,500
companies
trust
Statista
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!